Arbutus Biopharma Corporation is a publicly traded Canadian (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Vancouver, British Columbia and has research facilities in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Tekmira, as the company was formerly called, was formed as a wholly owned subsidiary of Inex Pharmaceuticals in 2005 after that company began collapsing after its regulatory and partnering strategy failed in 2004. Tekmira was fully spun out in 2007 and Tekmira absorbed the assets of Inex, which had been founded in 1992. More information...
According to PR-model, arbutusbio.com is ranked 2,250,524th in multilingual Wikipedia, in particular this website is ranked 1,350,412th in English Wikipedia.
The website is placed before ztn.com.pl and after stammapostelbesuch.de in the BestRef global ranking of the most important sources of Wikipedia.
